The observation that the siRNA-induced knock-down is associated with apoptosis and growth arrest in these cells suggests that Hsp32 serves as an important survival factor in ALL cells and thus may represent a potential therapeutic target. Here, HMOX1 is linked to acute lymphoblastic leukemia.